ImmunoPrecise Antibodies (IPA) Net Assets

IPA Net Assets in 2023: $57.80M

As of 25 Oct 2024, ImmunoPrecise Antibodies net assets is $57.80M, an decrease of -23.22% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the ImmunoPrecise Antibodies overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.

ImmunoPrecise Antibodies Net Assets History from 2019 to 2024

IPA Net Assets History by year

View the Top Net Assets Companies